Published in Rev Infect Dis on May 26, 1989
Toll-like receptor-2 mediates mycobacteria-induced proinflammatory signaling in macrophages. Proc Natl Acad Sci U S A (1999) 4.49
Mechanisms of stimulation of interleukin-1 beta and tumor necrosis factor-alpha by Mycobacterium tuberculosis components. J Clin Invest (1993) 2.38
Activation of the interleukin 6 gene by Mycobacterium tuberculosis or lipopolysaccharide is mediated by nuclear factors NF-IL6 and NF-kappa B. Proc Natl Acad Sci U S A (1994) 1.50
Lung cell responses to M. tuberculosis in genetically susceptible and resistant mice following intratracheal challenge. Clin Exp Immunol (2004) 1.08
Protein deficiency induces alterations in the distribution of T-cell subsets in experimental pulmonary tuberculosis. Infect Immun (1998) 1.01
Regulation of T-cell proliferative responses by cells from solid lung tissue of M. tuberculosis-infected mice. Immunology (1991) 0.93
Mycobacterial antigen complex A60-specific T-cell repertoire during the course of pulmonary tuberculosis. Infect Immun (1993) 0.90
Intracranial tuberculoma developing during therapy for tuberculous meningitis. West J Med (1990) 0.85
Depletion of endogenous interleukin-10 augments interleukin-1 beta secretion by Mycobacterium bovis BCG-reactive human cells. Clin Diagn Lab Immunol (1997) 0.85
Erythrocyte receptor (CD2)-bearing T lymphocytes are affected by diet in experimental pulmonary tuberculosis. Infect Immun (1990) 0.82
Effects of essential fatty acid deficiency on prostaglandin E2 production and cell-mediated immunity in a mouse model of leprosy. Infect Immun (1997) 0.80
Role of soluble interleukin-2 receptor levels in patients with latent tuberculosis. Lung (2006) 0.78
Tumour Necrosis Factor-alpha Production and Immune Cell Activation in Tuberculous Meningitis. Mediators Inflamm (1994) 0.78
Ultraviolet-irradiated monocytes efficiently inhibit the intracellular replication of Mycobacterium avium intracellulare. J Clin Invest (1992) 0.76
Mycobacterial infections in AIDS. Can J Infect Dis (1991) 0.75
The risk of tuberculosis related to tumour necrosis factor antagonist therapies: a TBNET consensus statement. Eur Respir J (2010) 2.56
Human immune response to Mycobacterium tuberculosis antigens. Infect Immun (1991) 2.39
Expression of tumor necrosis factor in vitro by human mononuclear phagocytes stimulated with whole Mycobacterium bovis BCG and mycobacterial antigens. Infect Immun (1988) 2.21
Depressed T-cell interferon-gamma responses in pulmonary tuberculosis: analysis of underlying mechanisms and modulation with therapy. J Infect Dis (1999) 2.06
Direct stimulation of monocyte release of interleukin 1 by mycobacterial protein antigens. J Immunol (1986) 2.05
Human Mycobacterium tuberculosis-reactive CD4+ T-cell clones: heterogeneity in antigen recognition, cytokine production, and cytotoxicity for mononuclear phagocytes. Infect Immun (1991) 1.89
Mapping of T cell epitopes of the 30-kDa alpha antigen of Mycobacterium bovis strain bacillus Calmette-Guérin in purified protein derivative (PPD)-positive individuals. J Immunol (1995) 1.40
Increased interleukin-1 production and monocyte suppressor cell activity associated with human tuberculosis. Am Rev Respir Dis (1986) 1.35
Enhanced responses to Mycobacterium tuberculosis antigens by human alveolar lymphocytes during active pulmonary tuberculosis. J Infect Dis (1998) 1.34
Tumor necrosis factor is the major monocyte product that increases complement receptor expression on mature human neutrophils. Blood (1988) 1.32
Examining a paradox in the pathogenesis of human pulmonary tuberculosis: immune activation and suppression/anergy. Tuber Lung Dis (1997) 1.13
Dyscoordinate expression of tumor necrosis factor-alpha by human blood monocytes and alveolar macrophages. Am Rev Respir Dis (1989) 1.08
Enhanced production of recombinant Mycobacterium tuberculosis antigens in Escherichia coli by replacement of low-usage codons. Infect Immun (2000) 1.08
Opsonizing antibodies (IgG1) up-regulate monocyte proinflammatory cytokines tumour necrosis factor-alpha (TNF-alpha) and IL-6 but not anti-inflammatory cytokine IL-10 in mycobacterial antigen-stimulated monocytes-implications for pathogenesis. Clin Exp Immunol (2001) 1.02
PPD-specific IgG1 antibody subclass upregulate tumour necrosis factor expression in PPD-stimulated monocytes: possible link with disease pathogenesis in tuberculosis. Clin Exp Immunol (2000) 0.99
Instability of tuberculin and Candida skin test reactivity in HIV-infected Ugandans. The Uganda-Case Western Reserve University Research Collaboration. Am J Respir Crit Care Med (1998) 0.98
Induction of monocyte expression of tumor necrosis factor alpha by the 30-kD alpha antigen of Mycobacterium tuberculosis and synergism with fibronectin. J Clin Invest (1996) 0.94
The immunology of tuberculous pleurisy. Semin Respir Infect (1988) 0.92
Cell membrane is a major locus for ultraviolet B-induced alterations in accessory cells. J Clin Invest (1990) 0.88
T cell activation by mycobacterial antigens in inflammatory synovitis. Cell Immunol (1991) 0.86
Deleterious effect of ultraviolet-B radiation on accessory function of human blood adherent mononuclear cells. Clin Exp Immunol (1987) 0.84
Duration of fever during treatment of infective endocarditis. Medicine (Baltimore) (1992) 0.84
Tuberculosis vaccines: how close to human testing? Tuber Lung Dis (1997) 0.81
Proinflammatory cytokine and human immunodeficiency virus RNA levels during early Mycobacterium avium complex bacteremia in advanced AIDS. J Infect Dis (1998) 0.80
Screening of a cosmid library of Mycobacterium bovis BCG in Mycobacterium smegmatis for novel T-cell stimulatory antigens. Res Microbiol (1993) 0.76
Pentoxifylline in human immunodeficiency virus- positive tuberculosis: safety at 4 years. J Infect Dis (1998) 0.76
More on zidovudine and HIV-related thrombocytopenia. N Engl J Med (1989) 0.75
Testing for AIDS: more problems with predictive values. JAMA (1986) 0.75
Regulation of antigen-induced blastogenesis and interleukin-2 expression by adherent mononuclear cells in humans infected with Schistosoma mansoni. J Infect Dis (1990) 0.75